OBJECTIVE	To establish the optimum oral daily dose of micronized medroxyprogesterone acetate , given in combination with a fixed oral dose of estrone ( E1 ) sulfate as hormone replacement therapy , that provides endometrial protection and induces cessation of vaginal bleeding .\